Monitoring mechanisms in mammalian ribosome biogenesis
Monitoring mechanisms in mammalian ribosome biogenesis
批准号:
8711482
负责人:
DIMITRI G PESTOV
金额:
$30.01万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-01 至 2016-12-31
关键词:
AddressAnabolismAnimal ModelAntineoplastic AgentsBiogenesisBiologicalCell Cycle ArrestCell NucleolusCell physiologyCellsComplexDefectDiseaseDrug TargetingEnsureEnzymesEukaryotaExonucleaseExoribonucleasesGatekeepingGeneticGrantGrowthInduced MutationLinkMalignant NeoplasmsMammalian CellMammalsMediatingMessenger RNAMetabolicModelingMolecularMolecular ConformationMolecular MachinesMonitorMusMutationOrganismOutcomePathogenesisPathway interactionsPhosphodiesterase IPlayProcessProteinsProteomeQuality ControlRNARNA DecayRegulationResearchRibonucleasesRibosomal ProteinsRibosomal RNARibosomesRoleSignal TransductionSiteSmall Nucleolar RNAStressSystemTestingToxic effectYeastsbasebiological adaptation to stressdisease-causing mutationmutantnanomachinenovel diagnosticsnucleaseoverexpressionpoly A specific exoribonucleaseprotein complexrRNA Precursortheoriestool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ribosomes are biological nanomachines that carry out synthesis of the entire cellular proteome. Cells require a large number of ribosomes to make proteins, especially during periods of active growth and proliferation. Each ribosome in eukaryotes is manufactured through an elaborate assembly pathway that requires more than 200 accessory protein factors. Like any other complex assembly process, biosynthesis of ribosomes generates a certain fraction of defective products and kinetically trapped intermediates. How do cells distinguish between ribosomes that are built correctly and those that are not? The main objective of the proposed research is to answer this question by elucidating the mechanisms underlying quality control of ribosome synthesis in mammalian cells. We use mouse cells in our studies because surveillance mechanisms in mammals differ in many aspects from those in other model organisms such as yeast. One of such differences is that defects in ribosome formation in mammals induce a p53-mediated nucleolar stress response, which is mechanistically not completely understood. Because the framework of preribosomes, like the ribosome itself, is made of RNA, ribonucleases play a key role in dismantling defective ribosome precursors. Here, we wish to establish the pathway through which exoribonucleases start the process of elimination of the defective preribosomes. Our project has three specific aims. 1. Determine the role of the mammalian exosome in the degradation of misassembled pre-60S subunits. We will determine whether the exosome functions in primary surveillance of misassembled pre-60S subunits or acts as a scavenger and how these activities may be regulated through candidate adaptors. 2. Identify structural features of the pre-60S subunit that control whether it will be processed or degraded. Our model is that certain components of preribosomes act as gatekeepers that control nuclease access to pre-rRNA. This will be tested by dissecting the interactions between the exonuclease Xrn2 and the 5.8S RNA-ribosomal protein complex in pre-60S subunits. 3. Determine if pre-rRNA decay products play a role in the nucleolar stress response induced by mutations in ribosome assembly factors and by anticancer drugs that block ribosome maturation, both of which significantly increase pre-rRNA breakdown by nucleases. Together, these studies will test the hypothesis that pre-rRNA surveillance by mammalian exoribonucleases serves the dual function of enabling accurate synthesis of ribosomes under normal circumstances, and initiating stress signaling when the system becomes overloaded.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Inhibition of post-transcriptional steps in ribosome biogenesis confers cytoprotection against chemotherapeutic agents in a p53-dependent manner.
抑制核糖体生物发生后的转录后步骤以p53依赖性方式对化学治疗剂赋予细胞保护作用。
DOI:
10.1038/s41598-017-09002-w
发表时间:
2017-08-22
期刊:
Scientific reports
影响因子:
4.6
作者:
[Sapio RT, Nezdyur AN, Krevetski M, Anikin L, Manna VJ, Minkovsky N, Pestov DG]
通讯作者:
Pestov DG
DOI:
10.1261/rna.2615311
发表时间:
2011-08
期刊:
RNA
影响因子:
4.5
作者:
[N. Shcherbik;D. G. Pestov]
通讯作者:
N. Shcherbik;D. G. Pestov
DOI:
10.1093/nar/gkq1050
发表时间:
2011-03
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Wang M, Pestov DG]
通讯作者:
Pestov DG
DOI:
10.1177/1947601910381382
发表时间:
2010-07-01
期刊:
Genes & cancer
影响因子:
--
作者:
[Shcherbik N, Pestov DG]
通讯作者:
Pestov DG
DOI:
10.1093/nar/gku787
发表时间:
2014
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Wang M, Anikin L, Pestov DG]
通讯作者:
Pestov DG
共 8 条
Nucleolar signaling in cancer
-
批准号:10064617
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2019
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:7008102
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:7575779
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:7340764
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:7516545
-
项目类别:
-
资助金额:$13.21万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:8500343
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:7169644
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:8296278
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:6859747
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
Monitoring mechanisms in mammalian ribosome biogenesis
-
批准号:8187767
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2005
-
负责人:DIMITRI G PESTOV
-
依托单位:
海外基金